|
gptkbp:instance_of
|
gptkb:vaccine
|
|
gptkbp:administered_by
|
adults
elderly
adolescents
injection
|
|
gptkbp:age_group
|
2 months and older
|
|
gptkbp:associated_with
|
Herd immunity
|
|
gptkbp:average_temperature
|
2 to 8 degrees Celsius
|
|
gptkbp:booster_recommended_every
|
10 years
|
|
gptkbp:can_be_administered_with
|
antipyretics
|
|
gptkbp:can_be_combined_with
|
gptkb:tetanus_toxoid
gptkb:MMR_vaccine
gptkb:varicella_vaccine
pertussis vaccine
|
|
gptkbp:can_cause
|
fatigue
headache
muscle pain
nausea
mild fever
|
|
gptkbp:clinical_trial
|
Phase III
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
|
|
gptkbp:developed_by
|
gptkb:diphtheria_toxin
|
|
gptkbp:first_introduced
|
1920s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
diphtheria toxoid
|
|
gptkbp:immunity_duration
|
10 years
|
|
gptkbp:inactivated_by
|
gptkb:formaldehyde
|
|
gptkbp:included
|
childhood vaccination schedule
|
|
gptkbp:is
|
live vaccine
|
|
gptkbp:is_effective_against
|
diphtheria bacteria
existing diphtheria infection
|
|
gptkbp:is_part_of
|
gptkb:Tdap_vaccine
routine immunization schedule
Td vaccine
DTa P-Hib-IPV combination vaccine
|
|
gptkbp:is_recommended_by
|
gptkb:CDC
gptkb:WHO
|
|
gptkbp:is_recommended_for
|
gptkb:children
|
|
gptkbp:is_used_in
|
travel vaccinations
|
|
gptkbp:manufacturer
|
various pharmaceutical companies
|
|
gptkbp:marketed_as
|
various brand names
|
|
gptkbp:part_of
|
gptkb:DTa_P_vaccine
|
|
gptkbp:produced_by
|
bacterial fermentation
|
|
gptkbp:regulatory_compliance
|
FDA approved
|
|
gptkbp:requires
|
informed consent
initial series of vaccinations
|
|
gptkbp:safety_features
|
generally safe
|
|
gptkbp:side_effect
|
local reaction at injection site
|
|
gptkbp:suitable_for
|
pregnant women without consultation
immunocompromised individuals without consultation
|
|
gptkbp:type
|
inactivated toxin
|
|
gptkbp:used_for
|
prevention of diphtheria
|
|
gptkbp:used_in
|
immunization programs
|
|
gptkbp:bfsParent
|
gptkb:Boostrix
|
|
gptkbp:bfsLayer
|
5
|